⚕ For healthcare professionals & patients — informational use only, not a substitute for medical advice. 15,548 products indexed

CETROTIDE

CETRORELIX · by MARTIN DOW MARKER

PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES Anti-gonadotrophic agent/Luteinising hormone releasing antagonist MARTIN DOW MARKER

Composition

lnj 0.25 mg: Cetrorelix acetate 250 mcg. Inj 3 mg: Cetrorelix acetate 3000 mcg.

Indications & Dosage

Adjunct in the treatment of female infertility: By SC INJ: Adults (female): Single-dose regimen: 3 mg given when serum oestradiol levels show appropriate stimulation response, usually stimulation day 7 (range days 5-9). If hCG is not administered within 4 days, continue cetrorelix at 0.25 mg/day until hCG is administered. Multiple-dose regimen:250 mcg once daily, dose to be administered in the morning, starting on day 5 or 6 of ovarian stimulation with gonadotrophins (or each evening starting on day 5 of ovarian stimulation), continue throughout administration of gonadotrophin including day of ovulation induction (or evening before ovulation induction), dose to be injected into the lower abdominal wall.

Administration

Administer by SC inj. The needle should be inserted completely into the skin at a 45-degree angle.

Stability

Store in outer carton. Once mixed, solution should be used immediately. 0.25 mg vial: Store under refrigeration at 2C-8C (36F-46F). 3 mg vial: Store at Controlled room temperature at 25C (77F); excursions permitted to 15C-30C (59F-86F).

Contraindications

Moderate to severe renal or hepatic impairment

Precautions

Should only be prescribed by fertility specialist.

Side Effects

Nausea, headache, injection site reactions, rarely hypersensitivity reactions.